TSMC (2330 TT/TSM) reportedly eyes further CoWoS price hikes of up to 20%, CTEE reports
Newsquawk Staff ·
TSMC (2330 TT/TSM) reportedly eyes further CoWoS price hikes of up to 20%, CTEE reports.
What it means
Reports of further price rises on advanced packaging capacity fit the established pattern in tight-supply niches: the sole qualified supplier of a chokepoint input with a qualified-capacity constraint tends to reprice incrementally and repeatedly rather than in one step, and prior rounds of such repricing in leading-edge foundry services have been absorbed by customers because the alternative is lost allocation rather than a cheaper vendor. The relevant channel is gross margin on a constrained, high-demand service line, not volume, since capacity remains sold out; for the buyer side, the question is whether hyperscaler and accelerator customers pass the cost into end pricing or absorb it, which historically has been the former where end demand is strong. Single-source press reports of this kind have a mixed record, and the pattern is for the company to decline comment on pricing, leaving confirmation to the next results call or capacity commentary. Follow-ons worth noting are any signal that competitors or outsourced assembly providers can qualify comparable packaging capacity, which is the mechanism that has historically capped pricing power in past tightening cycles, and whether lead times are lengthening in parallel, since price hikes accompanied by stable lead times suggest margin expansion rather than scarcity escalation. As an unconfirmed media report rather than a company announcement, the read is directional.
Sources
- Microsoft (MSFT) to offer buyouts to 60k workers in latest cost-cut, reports Bloomberg TV
- Anthropic files for IPO; applied to list Class A common stock on Nasdaq Global select market under the symbol 'ANT'
- US BROKER MOVES: TSLA upgraded at Barclays; FICO downgraded at Wells Fargo
- Meta (META) announces) launches USD 22.5bln Class A common stock offering and 250mln depositary shares offering
- Foxconn (2317 TT) has brought online an AI factory powered by an NVIDIA (NVDA) DGX supercomputing cluster
Related headlines
- EUROPEAN OPEN: VOW3 GY plans USD 4bln Georgia investment; FRAS LN raises BOSS GY stake above 50%; ROP SW divarasib cuts mortality risk; AZN LN plans sone-ve regulatory submission; BP/ LN settles remaining Deepwater Horizon claims11 hours ago
- PRE-MARKET INDIAN STOCKS NEWS: Earnings including Infosys, Bharat Petroleum, Bank of India, IndusInd Bank, Kotak Mahindra Bank, Tata Motors CV15 hours ago
- FTC and 20 states sue Dollar General (DG), alleging years of deceptive pricing practices that charged customers more at checkout than the advertised shelf prices and cost consumers millions2 hours ago
- US Midterms (8 days out): Democrats’ early-vote lead narrows in 7 states; Texas and Nebraska flip to Republicans3 hours ago
- Newsquawk Daily European Opening News - 26th October 202613 hours ago
- US forces in the Middle East are reportedly prepared to launch major strikes against Iran within 96 hours of Trump's approval, CNN reports12 hours ago
- Schneider Electric (SU FP) to sell EUR-denominated notes in a six parter11 hours ago
- Truist (TFC) reportedly considers sale of AFCO26 min ago
- CRUDE WRAP: WTI (Z6) SETTLES USD 1.51 LOWER AT 101.76/BBL; BRENT (Z6) SETTLES USD 0.96 LOWER AT USD 110.74/BBL36 min ago
- OpenAI launches Chat GPT 6.1 Terra1 hour ago
- Apple (AAPL) says aware of issue on small number of iPhone duos, affecting inner display of iPhone Duo2 hours ago
- Newsquawk Daily US Conference Calendar - 27th October 2026: TMO, BMY, GEV2 hours ago
- Apple (AAPL) iPhone Duo draws early complaints of the screen cracking2 hours ago
- FHFA Director Pulte says we are taking more action this week in the credit scoring industry to ensure competition is real and not fake, or manipulated3 hours ago
- Merck’s (MRK) Keytruda as monotherapy reduced the risk of disease progression or death by 43% vs chemotherapy for certain patients with advanced or recurrent endometrial cancer with mismatch repair deficient tumours3 hours ago